Protalix BioTherapeutics
PLX
#8601
Rank
C$0.35 B
Marketcap
C$4.16
Share price
-5.23%
Change (1 day)
68.53%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2026 (TTM): C$34.61 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are C$80.61 Million. In 2025 the company made an earning of -C$6.11 Million a decrease over its 2024 earnings that were of C$7.48 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$34.61 M-667.18%
2025 -C$6.11 Million-181.6%
2024 C$7.48 M-55.62%
2023 C$16.85 M-199.05%
2022 -C$17.02 Million-40.38%
2021 -C$28.55 Million-732.31%
2020 C$4.51 M-130.53%
2019 -C$14.79 Million189.85%
2018 -C$5.11 Million-95.29%
2017 -C$0.11 Billion308.12%
2016 -C$26.55 Million-32.37%
2015 -C$39.26 Million10.11%
2014 -C$35.65 Million-7.59%
2013 -C$38.58 Million
2011 -C$44.68 Million-19.39%
2010 -C$55.42 Million20.87%
2009 -C$45.85 Million32.26%
2008 -C$34.67 Million-5.46%
2007 -C$36.67 Million
2004 -C$0.24 Million12.35%
2003 -C$0.22 Million-11.1%
2002 -C$0.24 Million-57.03%
2001 -C$0.56 Million1.03%
2000 -C$0.55 Million-53.22%
1999 -C$1.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$9.99 B 28,094.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$1.23 B 3,391.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$0.27 M-99.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$1.75 B 4,852.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel